Dajiang Guo is an author at Cancer Australia specializing in option pricing, business, and financial economics.
Publications per year
1998–2021
4
4
Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer
Jianhuang Lin, Heng Liu, Takeshi Fukumoto et al. · Nature Communications · 2021 · 49 citations · Full text
Rows per page
1–4 of 4